What We're Reading | BioPharma Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Drugmakers Will Ask Trump to Pause Price Negotiations

Pfizer going ‘all in’ on obesity drug development, CEO Bourla says

Trump’s US FDA Reforms Need Center Director, Staff Support To Succeed, Former Leaders Say

BIO’s Crowley to advise Trump on FDA reform

Elon Musk ally leads attempt to seize control of psychedelic biotech Lykos

FTC Chair Lina Khan’s Exit Interview: ‘I Hope We Don’t See Backsliding’

Behind Moderna’s Quiet Gamble on China

Medicare Drug Price Explanations Shed Some Light on Future Talks

Eli Lilly and Andreessen Horowitz launch $500M venture fund

Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, Health Department agency says

What will viruses do next? AI is helping scientists predict their evolution

Drug From Bowel Bacteria Helps Blood Cancer Patients Facing Deadly Complication

GSK nears $1bn deal for biotech developing drug for rare tumour

Trump’s Denmark Tariff Threat Means New Uncertainty for Ozempic Drugmaker Novo Nordisk

Kennedy to ask Democrats to confirm him as HHS secretary

Vaccine makers’ shares jump after bird flu death in US

Aetna sues drugmakers over alleged price-fixing scheme

Stryker to buy Inari Medical for nearly $5B

Tiny fish on ketamine may show how drug eases depression

Centerview Partners Considers a Deal of Its Own After Record Year

China’s WuXi Biologics to sell Ireland vaccine facility to Merck for $500 million

Lilly-backed Golden Globes dubbed ‘Ozempic’s biggest night’

Reach our audience

Related Publications

Don't miss tomorrow's biopharma industry news

What We're Reading: Page 3

Jan 14, 2025

Jan 13, 2025

Jan 10, 2025

Jan 09, 2025

Jan 08, 2025

Jan 07, 2025

Jan 06, 2025